Matthew Jenusaitis

CIK 1357864 · Sr VP & Pres, Neuro Division · last filed 2025-12-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$165.4K

Companies

4

Total Filings

15

Lifetime Open-Market Net

-$17.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NVNO Director 16,545 $10.00 $165.4K $24.3K 4 2025-12-15
enVVeno Medical Corp (NVNOW) Delisted Director 6,925 $0.01 $44 $0 3 2022-12-02
enVVeno Medical Corp (HJLIW) Delisted Director 5,884 $0.56 $3.3K $10.0K 4 2021-09-15
ev3 Inc. (EVVV) Delisted Sr VP & Pres, Neuro Division 58,002 -$51.5K 4 2008-05-02

Recent Filings · Page 2 of 2

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-10-21 enVVeno Medical Corp (HJLIW) Delisted Grant (A) +62,500 $0 EDGAR
2008-05-02 ev3 Inc. (EVVV) Delisted Grant (A) +30,000 $0 EDGAR
2007-11-19 ev3 Inc. (EVVV) Delisted Sell (S) −3,420 -$51.5K EDGAR
2007-10-09 ev3 Inc. (EVVV) Delisted Grant (A) +16,447 $0 EDGAR
2007-01-24 ev3 Inc. (EVVV) Delisted Grant (A) +13,687 $0 EDGAR
Showing 1115 of 15
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.